Innovative Approach Developed for Removing Extra Chromosome 21 in Cells from Individuals with Down Syndrome Using CRISPR-Cas9 Genome Editing Technology
A research team led by Dr. Ryotaro Hashizume from the Graduate School of Medicine (a member of the Unit for Genomic Manipulation and Technology Development) has developed a pioneering technique for eliminating the extra copy of chromosome 21 in cells derived from individuals with Down syndrome…